SHANGHAI, July 31, 2025 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) (“ZTO” or the “Company”), a leading and fast-growing express delivery company in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2025 and its unaudited interim financial results for the half year ended June 30, 2025, after the U.S. market closes on August 19, 2025.

ZTO’s management team will host an earnings conference call at 8:30 P.M. U.S. Eastern Time on Tuesday, August 19, 2025, which is 8:30 A.M. Beijing Time on Wednesday, August 20, 2025.

Dial-in details for the earnings conference call are as follows:

A replay of the conference call may be accessible through August 26, 2025 by dialing the following numbers:                                    

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at http://zto.investorroom.com.

About ZTO Express (Cayman) Inc.

ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) (“ZTO” or the “Company”) is a leading and fast-growing express delivery company in China. ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage in China.

ZTO operates a highly scalable network partner model, which the Company believes is best suited to support the significant growth of e-commerce in China. The Company leverages its network partners to provide pickup and last-mile delivery services, while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.

For more information, please visit http://zto.investorroom.com.

For investor inquiries, please contact:

Investor Relations
Tel: (86) 21 5980 4508
Email: ir@zto.com

HANGZHOU, China, July 31, 2025 /PRNewswire/ — NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, “NetEase” or the “Company”), a leading internet and game services provider, today announced that it will report financial results for the 2025 second quarter on Thursday, August 14, 2025, before the open of the U.S. markets.

The earnings teleconference call with simultaneous webcast will take place at 8:00 a.m. Eastern Time on Thursday, August 14, 2025 (Beijing/Hong Kong Time: 8:00 p.m., Thursday, August 14, 2025). NetEase’s management will be on the call to discuss the quarterly results and answer questions.

Interested parties may participate in the conference call by dialing 1-914-202-3258 and providing conference ID: 10049137, 15 minutes prior to the initiation of the call. A replay of the call will be available by dialing 1-855-883-1031 and entering PIN: 10049137. The replay will be available through August 21, 2025.

This call will be webcast live and the replay will be available for 12 months. Both will be available on NetEase’s Investor Relations website at http://ir.netease.com/.

About NetEase, Inc.

NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, “NetEase”) is a leading internet and game services provider centered around premium content. With extensive offerings across its expanding gaming ecosystem, the Company develops and operates some of the most popular and longest running mobile and PC games available in China and globally.

Powered by one of the largest in-house game R&D teams focused on mobile, PC and console, NetEase creates superior gaming experiences, inspires players, and passionately delivers value for its thriving community worldwide. By infusing play with culture, and education with technology, NetEase transforms gaming into a meaningful vehicle to build a more entertaining and enlightened world.

Beyond games, NetEase service offerings include its majority-controlled subsidiaries Youdao (NYSE: DAO), an intelligent learning and advertising solutions provider, and NetEase Cloud Music (HKEX: 9899), a well-known online music platform featuring a vibrant content community, as well as Yanxuan, NetEase’s private label consumer lifestyle brand.

For more information, please visit: http://ir.netease.com/.

Contact for Media and Investors:

Investor Relations
Email: ir@service.netease.com
Tel: (+86) 571-8985-3378

HANGZHOU, China, July 31, 2025 /PRNewswire/ — Youdao, Inc. (“Youdao” or the “Company”) (NYSE: DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its second quarter 2025 financial results on Thursday, August 14, 2025, before the open of the U.S. markets.

The earnings teleconference call with simultaneous webcast will take place at 6:00 a.m. Eastern Time on Thursday, August 14, 2025 (Beijing/Hong Kong Time: 6:00 p.m., Thursday, August 14, 2025). Youdao’s management will be on the call to discuss the quarterly results and answer questions.

Dial-in details for the earnings conference call are as follows:

A live and archived webcast of the conference call will be available on the Company’s investor relations website at http://ir.youdao.com.

A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until August 21, 2025:

About Youdao, Inc. 

Youdao, Inc. (NYSE: DAO) is strategically positioned as an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals. Youdao now mainly offers learning services, online marketing services and smart devices – all powered by advanced technologies. Youdao was founded in 2006 as part of NetEase, Inc. (NASDAQ: NTES; HKEX: 9999), a leading internet technology company in China.

For more information, please visit: http://ir.youdao.com.

For investor and media inquiries, please contact:

In China:

Jeffrey Wang
Youdao, Inc.
Tel: +86-10-8255-8163 ext. 89980
E-mail: IR@rd.netease.com 

Piacente Financial Communications
Helen Wu
Tel: +86-10-6508-0677
E-mail: youdao@thepiacentegroup.com 

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: youdao@thepiacentegroup.com 

HONG KONG, July 31, 2025 /PRNewswire/ — Hong Kong International New Economic Research Institute Ltd. (INERI) announced today the successful integration of RWA Group Limited, a leading company in real-world asset tokenization, as its wholly-owned subsidiary. This reorganization unites two highly recognized institutions, combining INERI’s research-driven innovation with RWA Group’s commercialization expertise to deliver a powerful synergy that strengthens the RWA ecosystem in Asia.

INERI has long been known for its expertise in blockchain research, Web3 innovation, and fintech policy development, while RWA Group has built a strong reputation for its execution in supply chain finance, real estate tokenization, cross-border settlement, and stablecoin applications. By integrating RWA Group, INERI not only gains a market-facing commercialization platform but also infuses RWA Group with research-backed methodologies, patents, and technical depth. Together, they create a closed-loop framework that bridges technology development and market deployment, delivering a genuine “1+1>2” effect.

The INERI Board stated: “The strategic realignment of INERI and RWA Group represents a deep integration of research-driven capabilities and market-oriented expertise. We are confident this restructuring will serve as a pivotal catalyst for advancing the RWA industry. It will provide dual pillars of technological and market support across diverse application scenarios—including agricultural products, mineral resources, and cultural IP—propelling Asia’s RWA market to new heights.”

About RWA Group
RWA Group (formerly known as NFT China, now a wholly-owned subsidiary of the Hong Kong International Institute of New Economics) is a leading one-stop RWA service provider in Hong Kong’s Web3.0 industry, integrating digital financial advisory and infrastructure services. Founded by a professional team with extensive experience in blockchain technology, traditional finance, and digital asset infrastructure, RWA Group has established a deep business network covering Hong Kong, Mainland China, Southeast Asia, and beyond.

Since 2023, RWA Group has achieved sustained profitability and has successfully facilitated the tokenization issuance of multiple non-financial assets for clients including BYD and Faraday Future. The company was awarded second prize in the 2024 China Web3.0 Innovation and Entrepreneurship Competition and actively leads the development of industry technical specifications and evaluation standards, driving the standardization of the ecosystem.

www.rwa.ltd
The World’s First Non-Financial Real-World Asset Tokenization Platform
www.rwa.ltd has successfully integrated RWA issuance, trading, and advisory services, with its unique closed-loop service system—Technology Implementation, Compliance Assurance, Ecosystem Expansion—as its core competitive advantage. Moving forward, the platform will continue to serve as a bridge for the globalization of non-financial assets, advancing global collaboration and standardization in real-world asset digitization, and pioneering a new wave of digital transformation for physical assets.

BEIJING, July 31, 2025 /PRNewswire/ — A report from chinadaily.com.cn:

Sound can sometimes inspire a greater emotional reaction in people than visual stimuli, especially in movies and games. As the creator of the original soundtracks of many hit games and movies, including the groundbreaking BlackMyth: Wukong, 8082 Audio in Beijing granted exclusive access to China Daily online show Cultural Frontline, sharing creative stories of sound and music.

From the sound effects of the Monkey King armor, to the game’s sweeping and emotive Celestial Symphony, their magic extends much further than the synthesizer. Apart from the games, the studio’s artists also revealed the creative processes behind movie theme songs and even the sound effects used by modern electric vehicles. 

As the studio’s musical director, Zhai Jinyan told China Daily that a key source of their creative inspiration was Chinese culture, as many pieces of music and sound effects they design originate from the country’s musical landscape and its traditional instruments. 

“Our culture is our true root and soul, passed down through generations. Therefore, once we rediscover it, and draw nourishment from it, such nourishment can never be replaced by mere imagination.” Zhai added.

– Pilot Project on Home-based Heart Failure ICT Monitoring — Using Vital Data to Enable Early Medical Intervention –

KYOTO, Japan, July 31, 2025 /PRNewswire/ — OMRON Healthcare Co., Ltd., the world’s leading manufacturer and distributor of personal heart health products, has successfully concluded a three-month study demonstrating how remotely monitored vital signs can facilitate early medical intervention in patients with heart failure.

Logo1: https://kyodonewsprwire.jp/img/202507242643-O1-3Ei567mI 

Logo2: https://kyodonewsprwire.jp/img/202507242643-O2-8OYa6KT8 

Conducted in collaboration with Kyoto Prefectural University of Medicine, with support from Japan’s Ministry of Economy, Trade and Industry (METI), the study examined how real-time sharing of patient data, including blood pressure, body weight, and electrocardiogram (ECG) readings, can detect early signs of heart failure.

During the study, patients recorded daily measurements at home using OMRON’s smart health devices and the OMRON connect mobile app. This data was automatically shared with certified cardiovascular nurses and heart failure care experts who monitored the changes remotely. In cases where potential indicators of heart failure were observed, patients were contacted directly and referred for clinical evaluation.

Early detection is crucial for patients with heart failure, and this study saw warning signs detected in some 33% of participants (7 out of 21 patients), thereby enabling early intervention and treatment. By preempting the development of potentially severe or life-threatening symptoms, this approach can not only ease the burden on healthcare resources, but also bring clear benefits in reducing medical costs for patients.

Ultimately, over 90% of participants continued their daily health measurements for three months, with 86% reporting high satisfaction with the integration of home-based data into their personal health journey.

Such a system represents a significant advance on the standard approach in Japan, where patients self-report their symptoms via handwritten journals, which are only reviewed retrospectively during outpatient visits. With such appointments typically taking place every two to three months, there is a risk that conditions may worsen between visits, negating the opportunity for timely intervention.

Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202507242643/_prw_PI3fl_I1JsLa5e.jpg 

“By combining home-monitored data with a proactive follow-up from clinical staff, this study demonstrated a working model that improves patient outcomes and reduces the risk of heart failure complications,” said Professor Kiyoshi Matoba, Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine. “As we look to scale this model in Japan, we’ll continue refining its operations and validating its wider clinical and operational potential.”

Participants in the study utilized two key devices from OMRON Healthcare: OMRON Complete (HCR-7800T), Japan’s first upper-arm blood pressure monitor with integrated ECG functionality for home use, and Karada Scan (HN-300T2) body composition monitor. Both devices can automatically sync with the OMRON connect app, allowing users to track their vital signs daily and share the data seamlessly with healthcare providers.

The built-in ECG monitor also alerts users to signs of potential atrial fibrillation (AFib), a common type of arrhythmia whose impacts can include symptoms such as palpitations, shortness of breath, and fatigue, as well as clot formation in the atria and even strokes. However, because around 40% of individuals with AFib display no overt symptoms besides intermittent palpitations known as paroxysmal AFib, the condition can be difficult to detect with standard ECG tests during routine check-ups. Because patients with high blood-pressure and hypertension are at greater risk of developing AFib, regular self-monitoring and analysis via OMRON Healthcare’s unique Intellisense AFib technology is a valuable means of screening for undiagnosed symptoms.

This is all part of Going for ZERO, OMRON Healthcare’s vision to eliminate cardiovascular events by promoting ECG recording and blood pressure monitoring at home. Moving forward, OMRON Healthcare will continue to develop easy-to-use devices and services that enable anyone to monitor their heart health at home, while also maintaining its active engagement in academic initiatives in collaboration with healthcare professionals and researchers, contributing to healthier and more fulfilling lives for people around the world.

The full study results will be presented at the 29th Annual Meeting of the Japanese Heart Failure Society, scheduled for October 10-12, 2025.

About Kyoto Prefectural University of Medicine

Founded in 1872, Kyoto Prefectural University of Medicine (KPUM) is one of the oldest medical universities in Japan. Originally established as a hospital through public donations with the aim of providing Western medicine, KPUM later evolved into a university dedicated to training physicians and advancing medical science. Guided by its founding spirit, “Bringing world-class medicine to the local community,” KPUM spearheads innovative research and medical initiatives that contribute to public health and the development of the next generation of medical professionals.

About OMRON Healthcare

Committed to advancing health and empowering people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision “Going for Zero, Preventive Care for the Health of Society,” the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients reduce cerebro-cardiovascular events, aggravation of respiratory diseases, and restrictions due to chronic pain.

With well over 350 million units sold globally, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has striven to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, providing products and services in over 130 countries.

OMRON Healthcare Group is headquartered in Kyoto, Japan.

For more information, please visit:
Website: https://omronhealthcare.com/
LinkedIn: https://www.linkedin.com/company/omronhealthcare/